MetaBalance Peptide

Service Description

Treatment includes: Medical consultation Peptide: Tirzepatide GLP-1/GIP Pen kit for protocol administration A dual GLP-1/GIP agonist for appetite control, metabolic regulation, and weight loss. Phase 1 – Adaptation & Appetite Support Duration: approximately 10 weeks Focuses on helping the body gradually adapt while supporting appetite regulation, portion control, and improved metabolic response. Phase 2 & 3- Duration may vary depending on the patient’s medical conditions and desired weight goals. Phases 2 and 3 are determined after the medical consultation and evaluation of results. Estimated Program Duration: Approximately 52+ weeks depending on individual goals, tolerance, clinical response, and long-term treatment planning. Medical Follow-Up: Initial evaluation with continuous follow-up during each phase and dosage adjustment. Progression into Phase 2 & 3 is determined based on the individual response during Phase 1 and the results observed by the medical team, allowing for a safe and personalized continuation of the protocol. If the treatment needs to be discontinued based on medical recommendation, or if the expected response and results are not achieved during Phase 1, the patient will not be charged for Phase 2 & 3 of the protocol.